Compare Mounjaro vs Wegovy: Clinical Evidence & Pricing
Which Is Better Mounjaro or Wegovy: Understanding Prescription Weight Loss Options
When evaluating which is better between Mounjaro and Wegovy, it's essential to understand that both represent significant advances in prescription weight loss treatment. Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking natural hormones that regulate appetite and promote satiety after meals. This prescription-only medicine has been specifically licensed for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity. Mounjaro (tirzepatide), whilst primarily licensed for type 2 diabetes, works through a dual mechanism targeting both GIP and GLP-1 receptors.
The question of which is better between Mounjaro and Wegovy often depends on individual patient factors and clinical circumstances. Both treatments require careful medical supervision and are only available through prescription from registered healthcare providers. At EverydayMeds, our clinical team evaluates each patient's medical history, current medications, and weight management goals to determine the most appropriate treatment. This personalised approach ensures patients receive optimal care rather than a one-size-fits-all solution to prescription weight loss.
Mounjaro vs Wegovy Pricing: UK Prescription Weight Loss Costs
Understanding the cost implications when deciding which is better between Mounjaro and Wegovy is crucial for long-term treatment planning. Wegovy at EverydayMeds starts from £79.99 for the 0.25mg starter dose with our FIRST40 discount code for new customers, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our convenient bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. Returning customers can use discount code DOSE25 at checkout to achieve these final pricing levels.
When comparing which is better between Mounjaro and Wegovy from a value perspective, consider the complete treatment journey including dose escalation phases and maintenance costs. Wegovy follows a structured 20-week dose escalation schedule, allowing patients to gradually adjust to higher doses while minimising side effects. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering convenience and Reliable Supply continuity. Both treatments represent significant investments in health, but the clinical evidence supporting prescription weight loss makes them valuable options for appropriate candidates.
Clinical Evidence: Which Is Better Mounjaro or Wegovy for Weight Loss
Clinical trial data provides insight into which is better between Mounjaro and Wegovy, though direct head-to-head comparisons are limited due to different trial populations and designs. In the STEP clinical programme, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at two years, whilst the SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials in obesity populations have shown impressive results, though comparing which is better between Mounjaro and Wegovy requires careful consideration of trial methodologies. Both treatments work through incretin pathways but with different receptor targets, potentially offering distinct benefits for different patient populations. The decision of which is better ultimately depends on individual response, tolerability, and clinical circumstances rather than trial percentages alone.
How Wegovy Works: GLP-1 Mechanism for Prescription Weight Loss
Understanding Wegovy's mechanism helps clarify when it might be the better choice compared to Mounjaro for prescription weight loss. Wegovy functions as a GLP-1 receptor agonist, mimicking the action of naturally occurring incretin hormones that regulate blood glucose and appetite. This prescription-only medicine binds to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing food cravings between meals. The once-weekly injection provides sustained hormone levels, creating consistent appetite regulation throughout the week. Unlike rapid-acting appetite suppressants, Wegovy works gradually to reset eating patterns and portion sizes, supporting sustainable weight management when combined with lifestyle modifications.
EverydayMeds Ordering Process: Getting Your Prescription Weight Loss Treatment
Accessing prescription weight loss treatment through EverydayMeds involves a streamlined three-step process designed for convenience and clinical safety. The initial 3-minute online clinical assessment captures essential medical history, current medications, previous weight loss attempts, and treatment goals to help determine which is better between Mounjaro and Wegovy for your circumstances. Following assessment submission, our prescribing team conducts thorough clinical review within standard 3 working days, or express 24-hour service for urgent requirements. Once approved, your prescription-only medicine is dispatched via next-day delivery using temperature-controlled cold-chain logistics to ensure product integrity. Our GPhC-registered pharmacy (#9012878) maintains strict quality standards throughout the supply process, from clinical assessment to doorstep delivery.
Storage and Practical Considerations: Mounjaro vs Wegovy Comparison
Practical storage requirements often influence which is better between Mounjaro and Wegovy for individual lifestyles and travel requirements. Wegovy offers superior storage flexibility with 6 weeks room temperature stability below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage makes Wegovy more suitable for frequent travellers, business professionals, or anyone requiring extended periods away from refrigeration. Both treatments utilise pre-filled injection pens with simple administration, though Wegovy's FlexTouch pen system provides dose confirmation through audible clicks and visual indicators. The mandatory dose escalation schedule requires careful planning, starting at 0.25mg and gradually increasing to 2.4mg maintenance dose over 16 weeks. Proper storage at 2-8°C before first use ensures medication potency and treatment effectiveness throughout your weight management journey.
Which Is Better Mounjaro or Wegovy: Individual Patient Factors
Determining which is better between Mounjaro and Wegovy requires careful evaluation of individual patient characteristics beyond clinical trial data. Patients with type 2 diabetes may find dual benefits from Mounjaro's glucose-lowering properties alongside weight management effects, though this represents off-label use for obesity. Wegovy's specific licensing for weight management provides regulatory clarity for patients seeking dedicated obesity treatment. Some individuals respond better to single-target therapies like Wegovy's GLP-1 approach, whilst others may benefit from Mounjaro's broader incretin effects.
The question of which is better also encompasses practical lifestyle factors including injection frequency tolerance, storage requirements, and long-term cost considerations. Both treatments require indefinite use for sustained weight management, making tolerability and convenience crucial factors. Our clinical team at EverydayMeds evaluates these individual factors during consultation, ensuring treatment selection aligns with personal circumstances, medical history, and realistic expectations for prescription weight loss success.
Start Your Prescription Weight Loss Journey with EverydayMeds
Both Wegovy and Mounjaro are available through EverydayMeds, eliminating the need to decide which is better without professional guidance. New customers can begin their assessment today using discount code FIRST40 at checkout, whilst returning customers apply DOSE25 for optimal pricing. Our comprehensive clinical assessment takes just 3 minutes and provides our prescribing team with essential information to recommend the most suitable treatment option. With next-day cold-chain delivery and ongoing clinical support, EverydayMeds ensures your prescription weight loss journey begins safely and effectively. Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment and take the first step towards sustainable weight management with professional medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
